Li Shifeng, Huang Xianliang, Chen Huaiqing
Oklahoma Transplant Center, Oklahomna University Medical Center, Oklahoma City, Oklahoma 73104, USA.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011 Apr;28(2):405-9.
Human hepatocyte transplantation to treat liver-based metabolic deficiencies and acute liver failure has shown promising early improvement in liver function; however, long-term success has not been achieved. Stem cell transplantation to restore liver function as an alternative to whole liver transplantation has not been successful in humans. As alternative sources of cells for human hepatocyte transplantation, stem cells are under investigation. The liver extracellular matrix presents an ideal scaffold for stem cell differentiation into hepatocytes, as well as cell transplantation. The innovative technique of the decellularized liver matrix presents great potential as the scaffold for hepatocyte maturation and transplantation, and allows the development of engineered recellularized liver graft for transplantation.
人类肝细胞移植用于治疗基于肝脏的代谢缺陷和急性肝衰竭,已显示出早期肝功能有改善的良好前景;然而,尚未取得长期成功。作为全肝移植的替代方法,通过干细胞移植恢复肝功能在人类中尚未成功。作为人类肝细胞移植的细胞替代来源,干细胞正在研究中。肝脏细胞外基质为干细胞分化为肝细胞以及细胞移植提供了理想的支架。去细胞肝脏基质的创新技术作为肝细胞成熟和移植的支架具有巨大潜力,并允许开发用于移植的工程化再细胞化肝脏移植物。